1. "Clinical Cancer Research"
Formats
  1. Journal Article (1114)
  2. Meeting Abstract (177)
  3. Editorial (33)
  4. Review (17)
  5. Conference Paper (4)
  6. Correspondence (3)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (834)
  2. Solid Tumor Oncology Division (720)
  3. GSK Faculty (504)
  4. Genitourinary Oncology Service (269)
  5. Human Oncology and Pathogenesis Program (269)
  6. Surgery (254)

More Groups

People
  1. Howard Scher (83)
  2. Marc Ladanyi (83)
  3. David Solit (74)
  4. Mark Kris (64)
  5. Michael Berger (48)
  6. Gregory Riely (45)

More People

Years
  1. 2024 (17)
  2. 2023 (64)
  3. 2022 (75)
  4. 2021 (90)
  5. 2020 (87)
  6. 2019 (88)

More Years

Publications
  1. Clinical Cancer Research (1350)
Publishers
  1. American Association for Cancer Research (1350)

Results (1350)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ansamycins inhibit Akt activation and induce the 20S proteasomal degradation of Akt protein
    Meeting Abstract

    Basso, A. D.; Solit, D. B.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Comparison of signaling activities induced by paclitaxel and desoxyepothilone B
    Meeting Abstract

    Bergstralh, D. T.; Mackeigan, J. P.; Taxman, D. J.; Chou, T.; Ting, J. P.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Flavopiridol potentiates the effect of CPT-11 and docetaxel in human tumor xenografts
    Meeting Abstract

    Schwartz, G. K.; Motwani, M. V.; Shah, M. A.; She, J.; Sirotnak, F.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • The tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumors
    Meeting Abstract

    Moasser, M. M.; Basso, A. D.; Averbuch, S. D.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Crystal structures of the c-Abl tyrosine kinase domain in complex with STI-571 and a novel Bcr-Abl inhibitor, PD173955
    Meeting Abstract

    Swendeman, S.; Nagar, B.; Wisniewski, D.; Strife, A.; Lambek, C.; Liu, C.; Veach, D.; Bornmann, W.; Kuriyan, J.; Clarkson, B.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Acne-like rash predicts response in patients treated with Cetuximab (IMC-C225) plus Irinotecan (CPT-11) in CPT-11-refractory colorectal cancer (CRC) that expresses epidermal growth factor receptor (EGFR)
    Meeting Abstract

    Saltz, L.; Rubin, M. S.; Hochster, H. S.; Tchekmeydian, N. S.; Waksal, H. W.; Needle, M. N.; Lobuglio, A. F.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Quantification of Her 2/Neu gene amplification in breast carcinoma cell lines using a novel PCR/LDR technique
    Meeting Abstract

    Nathanson, D. R.; Culliford, A. T.; Nash, G. M.; Gerald, W.; Paty, P. B.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Studies with CWR22 xenograft models in nude mice suggest that ZD1839 (Iressa) may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer
    Meeting Abstract

    Sirotnak, F. M.; She, Y.; Lee, F.; Scher, H. I.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Phase I trial of human tyrosinase DNA vaccination in dogs with advanced malignant melanoma
    Meeting Abstract

    Bergman, P. J.; McKnight, J.; Novosad, A.; Chamey, S.; Farrelly, J.; Jeffers, Y.; Egan, M.; Craft, D.; Gallardo, H.; Riviere, I.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Development of 9-alkyl-8-benzyl-9H-purin-6-ylamines as inhibitors of the hsp90 family
    Meeting Abstract

    Chiosis, G.; Shtil, A.; Lucas, B.; Huezo, H.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save